Raily Aesthetic Medicine International Holdings Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Jianliang Song
Chief executive officer
CN¥933.0k
Total compensation
| CEO salary percentage | 96.5% |
| CEO tenure | 2.9yrs |
| CEO ownership | n/a |
| Management average tenure | 3.5yrs |
| Board average tenure | 3.9yrs |
Recent management updates
Recent updates
Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Held Back By Insufficient Growth Even After Shares Climb 37%
Oct 02
Benign Growth For Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Underpins Its Share Price
Jul 22Revenues Working Against Raily Aesthetic Medicine International Holdings Limited's (HKG:2135) Share Price Following 47% Dive
Apr 22Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Stock Rockets 39% As Investors Are Less Pessimistic Than Expected
Feb 07Raily Aesthetic Medicine International Holdings Limited's (HKG:2135) Popularity With Investors Is Under Threat From Overpricing
Dec 19Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Investors Are Less Pessimistic Than Expected
Aug 22Statutory Profit Doesn't Reflect How Good Raily Aesthetic Medicine International Holdings' (HKG:2135) Earnings Are
Sep 17CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -CN¥32m |
| Mar 31 2024 | n/a | n/a | -CN¥32m |
| Dec 31 2023 | CN¥933k | CN¥900k | -CN¥32m |
| Sep 30 2023 | n/a | n/a | -CN¥26m |
| Jun 30 2023 | n/a | n/a | -CN¥20m |
| Mar 31 2023 | n/a | n/a | -CN¥18m |
| Dec 31 2022 | CN¥647k | CN¥600k | -CN¥16m |
| Sep 30 2022 | n/a | n/a | -CN¥13m |
| Jun 30 2022 | n/a | n/a | -CN¥11m |
| Mar 31 2022 | n/a | n/a | -CN¥14m |
| Dec 31 2021 | CN¥1m | CN¥1m | -CN¥18m |
| Sep 30 2021 | n/a | n/a | -CN¥3m |
| Jun 30 2021 | n/a | n/a | CN¥11m |
| Mar 31 2021 | n/a | n/a | CN¥8m |
| Dec 31 2020 | CN¥1m | CN¥1m | CN¥4m |
| Sep 30 2020 | n/a | n/a | -CN¥25k |
| Jun 30 2020 | n/a | n/a | -CN¥4m |
| Mar 31 2020 | n/a | n/a | CN¥3m |
| Dec 31 2019 | CN¥2m | CN¥2m | CN¥10m |
Compensation vs Market: Jianliang's total compensation ($USD128.73K) is below average for companies of similar size in the Hong Kong market ($USD232.62K).
Compensation vs Earnings: Jianliang's compensation has increased whilst the company is unprofitable.
CEO
Jianliang Song (68 yo)
2.9yrs
Tenure
CN¥933,000
Compensation
Mr. Jianliang Song serves as an Executive Director at Raily Aesthetic Medicine International Holdings Limited and serves as its Chief Executive Officer since December 28, 2021. Mr. Song is responsible for...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board | 6.8yrs | CN¥852.00k | 53.1% HK$ 35.5m | |
| CEO & Executive Director | 2.9yrs | CN¥933.00k | no data | |
| Chief Financial Officer | no data | CN¥433.00k | no data | |
| Executive Director | 2.9yrs | CN¥558.00k | no data | |
| Company Secretary | 4yrs | no data | no data |
3.5yrs
Average Tenure
47yo
Average Age
Experienced Management: 2135's management team is considered experienced (3.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board | 6.8yrs | CN¥852.00k | 53.1% HK$ 35.5m | |
| CEO & Executive Director | no data | CN¥933.00k | no data | |
| Executive Director | 2.9yrs | CN¥558.00k | no data | |
| Independent Non-Executive Director | 3.9yrs | CN¥162.00k | no data | |
| Independent Non-Executive Director | 3.9yrs | CN¥162.00k | no data | |
| Independent Non-Executive Director | 3.9yrs | CN¥162.00k | no data |
3.9yrs
Average Tenure
48.5yo
Average Age
Experienced Board: 2135's board of directors are considered experienced (3.9 years average tenure).